Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.
Adaui V, Castillo D, Zimic M, Gutierrez A, Decuypere S, Vanaerschot M, De Doncker S, Schnorbusch K, Maes I, Van der Auwera G, Maes L, Llanos-Cuentas A, Arevalo J, Dujardin JC. Adaui V, et al. Among authors: vanaerschot m. PLoS Negl Trop Dis. 2011 May 10;5(5):e1021. doi: 10.1371/journal.pntd.0001021. PLoS Negl Trop Dis. 2011. PMID: 21572980 Free PMC article.
Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage.
Jara M, Berg M, Caljon G, de Muylder G, Cuypers B, Castillo D, Maes I, Orozco MDC, Vanaerschot M, Dujardin JC, Arevalo J. Jara M, et al. Among authors: vanaerschot m. PLoS One. 2017 Jul 25;12(7):e0180532. doi: 10.1371/journal.pone.0180532. eCollection 2017. PLoS One. 2017. PMID: 28742826 Free PMC article.
Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony.
Adaui V, Schnorbusch K, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, DE Doncker S, Maes I, Llanos-Cuentas A, Chappuis F, Arévalo J, Dujardin JC. Adaui V, et al. Among authors: vanaerschot m. Parasitology. 2011 Feb;138(2):183-93. doi: 10.1017/S0031182010001095. Epub 2010 Aug 3. Parasitology. 2011. PMID: 20678296
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent.
Vanaerschot M, Decuypere S, Downing T, Imamura H, Stark O, De Doncker S, Roy S, Ostyn B, Maes L, Khanal B, Boelaert M, Schönian G, Berriman M, Chappuis F, Dujardin JC, Sundar S, Rijal S. Vanaerschot M, et al. J Infect Dis. 2012 Sep 1;206(5):752-5. doi: 10.1093/infdis/jis424. Epub 2012 Jun 29. J Infect Dis. 2012. PMID: 22753945 Free PMC article.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.
Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, de Doncker S, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schönian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C, Dujardin JC, Berriman M. Downing T, et al. Among authors: vanaerschot m. Genome Res. 2011 Dec;21(12):2143-56. doi: 10.1101/gr.123430.111. Epub 2011 Oct 28. Genome Res. 2011. PMID: 22038251 Free PMC article.
(Post-) Genomic approaches to tackle drug resistance in Leishmania.
Berg M, Mannaert A, Vanaerschot M, Van Der Auwera G, Dujardin JC. Berg M, et al. Among authors: vanaerschot m. Parasitology. 2013 Oct;140(12):1492-505. doi: 10.1017/S0031182013000140. Epub 2013 Mar 12. Parasitology. 2013. PMID: 23480865 Review.
58 results